IMV (IMVIF) Operating Margin %: 0.00% (As of Dec. 2022)


IMVIF IMV Inc IMVIF
12 GF Score
Price $0.00
View Full Analysis

What is IMV Operating Margin %?

IMV IMVIF -99.95% 12 Operating Margin % is 0.00% as of Dec. 2022. GuruFocus rates IMVIF with a GF Score™ of 12/100.

Operating Margin % is calculated as Operating Income divided by its Revenue. IMV's Operating Income for the three months ended in Dec. 2022 was $-8.59 Mil. IMV's Revenue for the three months ended in Dec. 2022 was $0.00 Mil. Therefore, IMV's Operating Margin % for the quarter that ended in Dec. 2022 was 0.00%.

The historical rank and industry rank for IMV's Operating Margin % or its related term are showing as below:


IMVIF's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -86.77
* Ranked among companies with meaningful Operating Margin % only.

IMV's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

IMV's Operating Income for the three months ended in Dec. 2022 was $-8.59 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2022 was $-38.49 Mil.


IMV  (OTCPK:IMVIF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


IMV Operating Margin % Related Terms


IMV Operating Margin % Historical Data

* Premium members only.

The historical data trend for IMV's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMV Operating Margin % Chart

IMV Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25,636.67 -45,311.11 0.00 0.00 0.00

IMV Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMVIF vs RGTPQ, QBIO, RGIN: Operating Margin % Comparison

For the Biotechnology subindustry, IMV's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMV Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IMV's Operating Margin % distribution charts can be found below:

* The bar in red indicates where IMV's Operating Margin % falls into.


IMVIF
12GF Score
IMV Inc IMVIF
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IMV Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

IMV's Operating Margin % for the fiscal year that ended in Dec. 2022 is calculated as

Operating Margin %=Operating Income (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=-38.492 / 0
= %

IMV's Operating Margin % for the quarter that ended in Dec. 2022 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2022 ) / Revenue (Q: Dec. 2022 )
=-8.59 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.00% mean?
IMV (IMVIF) has a Operating Margin % of 0.00% as of Dec. 2022. Operating margin is the ratio of total operating income to net sales. View historical data on IMV and its competitors.
Is IMV's Operating Margin % too high?
IMV's current Operating Margin % is 0.00%. Overall, IMV has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does IMV's Operating Margin % compare to RGTPQ and QBIO?
IMV's Operating Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on IMV and its competitors. IMV's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMV stock overvalued right now?
IMV (IMVIF) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. IMV's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For IMV (IMVIF), the current Operating Margin % is 0.00% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IMV Business Description

Address 130 Eileen Stubbs Avenue, Suite 19, Dartmouth, NS, CAN, B3B 2C4
IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.
12GF Score

Get the complete analysis for IMVIF

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price